Boeing shares have whipsawed in recent months, pulling back after CEO Kelly Ortberg acknowledged that stabilizing 737 MAX production at 47 aircraft per month is taking longer than expected. With the stock trading near $197 after a slide of roughly 9% over the past month, the round-number $250 mark has become a focal point. It represents both a psychological milestone and a level that several analysts — including Wells Fargo and Morgan Stanley — have cited as a target, making it one of the most widely discussed objectives in the current Boeing debate.
Boeing is one of the world's two dominant commercial aerospace manufacturers alongside Airbus, and it is also a major defense contractor. After years of losses tied to the 737 MAX crisis and the pandemic, the company returned to annual profitability in 2025, reporting revenue of roughly $89.5 billion and delivering around 600 commercial aircraft. The stock's 52-week range spans from about $177 to $254, meaning the shares have already touched the $250 zone once before their recent retreat.
The central pillar of the bullish argument is Boeing's backlog, which management and analysts have cited at record levels — around $597 billion across commercial and defense programs. That book of orders provides unusual long-term revenue visibility. Analysts also point to a projected free-cash-flow inflection: as 737 MAX and 787 production rates stabilize and rise, Boeing's cash generation is expected to improve materially, with some bulls arguing annual free cash flow could eventually approach $10 billion.
Specific catalysts could accelerate the move. Certification of the 737 MAX 10, which Bank of America's Ronald Epstein expects "very soon," is viewed as a key driver because that variant represents a meaningful share of the 737 backlog. The first 777X delivery, targeted for 2027, is another milestone investors are watching. On the defense side, Boeing's segment backlog has remained resilient amid rising global munitions and tanker demand.
Reaching $250 is not simply a matter of waiting. Boeing's recovery has repeatedly been disrupted by execution issues. The most immediate risk is a potential strike by the Society of Professional Engineering Employees in Aerospace (SPEEA), whose contracts expire in early October — a scenario Bank of America flagged as the key near-term concern. A work stoppage would directly threaten the production ramp.
Beyond labor, wing-manufacturing bottlenecks have slowed 737 output, and certification testing for the long-delayed 777X could slip further into 2027. Boeing also carries significant debt relative to its recent earnings, and near-term results remain weak: consensus estimates still point to a modest loss for 2026, with the investment case resting heavily on a 2027 recovery. Regulatory scrutiny, including FAA inspection proposals tied to 737 MAX structural concerns, adds another layer of execution risk.
Wall Street's view on Boeing is notably constructive. The consensus among analysts tracking the stock is a Buy or Strong Buy, with an average 12-month price target near $274.85 — roughly 35–39% above recent prices. The range is wide, from around $246 on the low end to $305 at the high end, reflecting genuine disagreement about the pace of the turnaround. Within that spectrum, $250 sits near the conservative edge, aligned with Wells Fargo's Overweight initiation and Morgan Stanley's Hold-rated target. The broader consensus implies that $250 is not only achievable but potentially a stepping stone toward higher levels — provided execution improves.
From a technical standpoint, $250 is more than a round number. The stock's 52-week high near $254 places the $250 area squarely in a zone of prior overhead supply, where shares have previously encountered selling pressure. On the downside, the 52-week low near $177 and the recent consolidation around the $197–$200 zone serve as reference points. A sustained move toward $250 would likely require Boeing to first reclaim its longer-term moving averages and establish higher lows — signs that the multi-month downtrend has reversed rather than merely paused.
For traders seeking a more systematic way to track developments like Boeing's, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to manual research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. These signals can help traders discover new opportunities, keep an eye on existing positions, and identify changing market trends more efficiently than scanning charts alone.
The question of whether Boeing can reach $250 is realistic but not assured. The company's record backlog, restored profitability, and a Wall Street consensus target well above $250 give the objective meaningful support. At the same time, the path depends heavily on execution: stabilizing the 737 MAX ramp, avoiding a labor disruption, and advancing the 777X program. Investors weighing this stock price target should monitor production rates, the SPEEA contract vote, and any certification news — because those factors, more than the headline price, will determine whether $250 becomes a ceiling or a launchpad.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, BA has been loosely correlated with SARO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BA jumps, then SARO could also see price increases.